{"schema_version":"secwatch.filing_event.v1","accession":"0001156039-26-000006","form_type":"8-K","ticker":"ELV","cik":"0001156039","company_name":"Elevance Health, Inc.","filed_at":"2026-01-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.621562+00:00","generated_at":"2026-05-16T06:53:47.745837+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Elevance Health Q4 adj. EPS $3.33 on higher medical costs; FY2026 adj. EPS guide $25.50, down from $30.29","bullets":["Q4 2025 GAAP diluted EPS $2.47; adjusted $3.33; operating revenue $49.3B (+10% YoY).","Full year 2025 GAAP EPS $25.21; adjusted $30.29; operating revenue $197.6B (+13% YoY).","Health Benefits segment Q4 adjusted operating loss of $0.2B; benefit expense ratio 93.5% (+110 bps YoY).","FY2026 guidance: GAAP EPS at least $22.30; adjusted EPS at least $25.50; targeting 12% adjusted EPS growth in 2027.","Returned $4.1B to shareholders in 2025; quarterly dividend raised to $1.72 per share."],"urls":{"canonical":"https://secwatch.observer/filing/0001156039-26-000006","json":"https://secwatch.observer/filing/0001156039-26-000006.json","markdown":"https://secwatch.observer/filing/0001156039-26-000006.md","text":"https://secwatch.observer/filing/0001156039-26-000006.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1156039/000115603926000006/0001156039-26-000006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1156039/000115603926000006/elv-20260128.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T06:53:47.745837+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}